Exyn Technologies director granted 23,200 options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Exyn Technologies, Inc. director Michael Burychka reported receiving a grant of stock options to purchase 23,200 shares of common stock on August 3, 2026, with an exercise price of $1.82 per share. The options vest in three equal annual installments starting August 3, 2027 and expire on August 3, 2036.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F1 | 23,200 | $0.00 | $0.00 |
Footnotes (1)
- F1. On August 3, 2026 (the "Grant Date"), the Reporting Person was granted stock options to purchase 23,200 shares of the Issuer's common stock. These options vest in accordance with the following schedule: one-third of the shares on August 3, 2027 and one-third on each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Key Figures
Key Terms
Stock Option financial
vesting financial
exercise price financial
expiration date financial
service provider financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Exyn Technologies (EXYN) report for Michael Burychka?
What are the key terms of the 23,200 stock options granted at Exyn Technologies (EXYN)?
How do the Exyn Technologies (EXYN) options granted to Michael Burychka vest?
What is the exercise price and expiration date of the EXYN options granted to Michael Burychka?
How many Exyn Technologies (EXYN) options does Michael Burychka hold after this reported grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.